Differential enrichment of H3K9me3 in intrahepatic cholangiocarcinoma
Abstract Background Intrahepatic cholangiocarcinoma (ICC) is a malignant tumor, which poses a serious threat to human health. Histone 3 lysine 9 trimethylation (H3K9me3) is a post-translational modification involved in regulating a broad range of biological processes and has been considered as poten...
Main Authors: | Sheng Hu, Xuejun Wang, Tao Wang, Lianmin Wang, Lixin Liu, Wenjun Ren, Xiaoyong Liu, Weihan Zhang, Weiran Liao, Zhoujun Liao, Renchao Zou, Xiaowen Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-08-01
|
Series: | BMC Medical Genomics |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12920-022-01338-1 |
Similar Items
-
Septin 9 expression regulates ‘don't eat me’ signals and identifies an immune–epithelial class of intrahepatic cholangiocarcinoma
by: Ting ting Cai, et al.
Published: (2024-10-01) -
Intrahepatic Cholangiocarcinoma Associated with Intrahepatic Duct Stones
by: Hoon Hur, et al.
Published: (2009-01-01) -
The clinicopathological significance and prognostic impact of 14-3-3σ/stratifin expression on patients with surgically resectable intrahepatic cholangiocarcinoma
by: Su-Hung Wang, et al.
Published: (2025-01-01) -
MBD2 regulates the progression and chemoresistance of cholangiocarcinoma through interaction with WDR5
by: Da Wang, et al.
Published: (2024-09-01) -
UBA3 promotes the occurrence and metastasis of intrahepatic cholangiocarcinoma through MAPK signaling pathway
by: Zhang Huhu, et al.
Published: (2024-01-01)